| Bioactivity | Takeda103A is a potent inhibitor of GRK2. G protein-coupled receptors (GPCRs) are central to many physiological processes. Takeda103A has the potential for the research of heart failure[1]. | |||||||||
| Name | Takeda103A | |||||||||
| CAS | 865609-72-9 | |||||||||
| Formula | C24H23F2N7O | |||||||||
| Molar Mass | 463.48 | |||||||||
| Appearance | Solid | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
|||||||||
| Reference | [1]. Waldschmidt HV, et al. Structure-Based Design, Synthesis, and Biological Evaluation of Highly Selective and Potent G Protein-Coupled Receptor Kinase 2 Inhibitors. J Med Chem. 2016;59(8):3793-3807. |
Takeda103A
CAS: 865609-72-9 F: C24H23F2N7O W: 463.48
Takeda103A is a potent inhibitor of GRK2. G protein-coupled receptors (GPCRs) are central to many physiological processe
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.